In 2021, the market for Otoplasty worldwide was worth $1.05 billion US dollars. AMR Group projects that the market will reach US$ 1.90 billion by 2031, growing at a CAGR of 6.5 percent between 2022 and 2031.
Industry Overview
Otoplasty is described as a surgical as well as non-surgical process for correcting external ear defects and deformities. The defect can be in the morphology and structure of the external ear, such as trauma damage, an absent external ear, deformation, and so on. The procedure used in Otoplasty to correct an external ear deformity or defect includes augmenting or shaping the cartilaginous support framework of the pinna, among other things.
The Otoplasty market, also known as a cosmetic ear surgical procedure, is a method for repositioning, reshaping, or resizing the ears. It entails surgically reworking the pinna or outer ear to improve its appearance or correct any deficiencies. The surgery is more common in childhood, but it can be performed at any moment after the ears have reached their full size. It could also be done when the child is three years old. If the ear structure has deformities, otoplasty can be used to correct them. The procedure can treat macrotia, a condition characterized by excessively large earlobes as well as protruding ears. Scarring, asymmetrical ear placement, changes in skin sensation, stitch issues, and alternate versions are all risks associated with otoplasty. Natural deformities and extremities, such as cryptotic ears, bat ears, Stahl's ear deformity, macrotic ears, question mark ears, etc., are also contributing to the global market's projected expansion.
Market Dynamics
The Otoplasty market is expected to expand due to a rise in the number of people suffering from congenital ear deformities such as hemifacial microsomi as well as treacher collins syndrome, in addition to the development of new Otoplasty products. Increased adoption of plastic procedures around the world. Increased awareness about the looks of the ear among the youth, a growth in cases of trauma to the external ear caused by blasts, puncture, or damage caused by blunt objects. An increase in screening for deformities at birth, and the psychological impact of appearance, looks, and beauty on the young generation are some of the major and vital factors that will likely augment the growth of the otoplasty market in the coming years.
In recent years, people's disposable income has increased, as has their acceptance of plastic and aesthetic surgeries around the world, intense marketing opportunities for the growth of the otoplasty market in the above-mentioned forecast timeline. Complications as well as discomfort associated with otoplasty. In addition to distortion of the structure of the ear caused by overcorrection of deformed features and reappearance of ear protrusion, are likely to function as market restraints for otoplasty growth. The formation of abnormal scar tissue is the most significant and immediate challenge to the market's growth.
COVID Impact
The COVID-19 pandemic has had a negative impact on the Otoplasty Markets, particularly the pharmaceutical and biotech industries. All surgical procedures were halted during the peak of the COVID-19 pandemic. The government's order to stay at home to prevent the spread of the virus has had a negative impact on the market. Furthermore, the Royal College of Surgeons (RCS) ranked cosmetic surgery as a priority 4 procedure, the lowest priority surgery. As a result of the decrease in COVID-19 cases and the lifting of government restrictions, safe cosmetic surgery procedures resumed. As a result, the current market growth rate is slow, but it is expected to improve in the coming few years.
Regional Trend
Geographically, the global Otoplasty market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Globally, North America dominates the Otoplasty market due to the availability of best technological products & processes, the rising demand among youth for otoplasty procedures, as well as the presence of highly specialised surgeons, are some of the factors assisting this region's dominance over the forecast period. According to the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS), there are currently 13,000 otolaryngologists in the organization.
Asia Pacific is expected to have a higher rate because the government is working hard to raise awareness about hearing defects and is heavily investing in R&D activities to conduct extensive research and clinical trials for the same. China, Japan, Australia, Singapore, and New Zealand are the significant contributors to the otoplasty market. Furthermore, rising awareness of hearing defects, rising spending power, and rising medical tourism due to affordable treatment costs are driving market growth.
Competitive Landscape
Key players operating in the global Otoplasty market are AbbVie Inc., Aetna Inc., Allergan, Bausch Health Companies Inc., Cape ENT, Cosmetic Surgery Partners (CSP), EarBuddies, Earfold, Gulf Medical Company, Ltd., Invotec International Inc., Karidis Cosmetic Surgery Clinic London, Long Island Plastic Surgical Group, MACS Cosmetic Clinic (Harley Street), Medbelle - Bloomsbury Way, Nazarian Plastic Surgery, Phoenix medical systems Pvt. ltd., Piedmont Plastic Surgery & Dermatology, Sklar Surgical Instruments, Surtex Instruments Limited, and Westlake Dermatology among others. In November 2015, the prominent company Allergan acquired Northwood Medical Innovation Ltd with an objective to develop products for the treatment of prominent ears in geriatrics and to enhance its product portfolio into the market.
Key USP’s-
Male procedures totaled 1.1 million, with 0.3 million being surgical and 0.9 million being minimally invasive. Because of their shorter treatment cycle, minimally invasive operations are becoming more popular. Cosmetic procedures cost approximately USD 16.7 billion in the United States alone. In the South Atlantic, approximately 3.8 million (25%) procedures were performed.
Market Segmentation
Based upon the Type used in Otoplasty market is segmented into three major segments Ear Augmentation, Ear Reduction and Ear Pin Back in the Otoplasty process. Based on Technique, the Otoplasty market is segmented into Surgical and Non- Surgical, further Surgical segment is bifurcated into Correlation of earlobe prominence, Conchal alteration and Anti-helical fold manipulation whereas Non- Surgical is bifurcated into tissue molding and others. Among the technique segments, in 2022, the Surgical segment is estimated to account for the largest share of the Otoplasty market. The major factors contributing to the large market share of this segment are the because of the high availability of surgical augmentation of the ear and rising preferences for cosmetic surgery for ear augmentation among the patients. Based upon the Age in Otoplasty market is segmented into are Ages 13-19, 20-29, 30-39, 40-54, 55 and Above in the Otoplasty process. Based upon the Gender in Otoplasty market is segmented into are Male and Female.
End user segment of Otoplasty market is further divided into Cosmetic Surgery Centres, Ambulatory Surgical Centres, and Hospitals. The Cosmetic Surgery Centres and Hospitals segment was accounted for the largest share of the Otoplasty market. As to the American Society of Plastic Surgeons, in 2018, almost 17 million cosmetic treatments were known performance which was a 9% rise from 2017. In 2020, around 53,095 ear surgery was done by the Plastic Surgery Organization.
By Type
• Ear Augmentation
• Ear Reduction
• Ear Pin Back
By Technique
• Surgical
o Correlation of earlobe prominence
o Conchal alteration
o Anti-helical fold manipulation
• Non- Surgical
o Tissue Molding
o Others
By Age
• 13-19
• 20-29
• 30-39
• 40-54
• 55 and Above
By Gender
• Male
• Female
By End User
• Cosmetic Surgery Centres
• Ambulatory Surgical Centres
• Hospitals